Your browser doesn't support javascript.
loading
IMbrave 050: a Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation.
Hack, Stephen P; Spahn, Jessica; Chen, Minshan; Cheng, Ann-Lii; Kaseb, Ahmed; Kudo, Masatoshi; Lee, Han Chu; Yopp, Adam; Chow, Pierce; Qin, Shukui.
Afiliação
  • Hack SP; Genentech, Inc, 1 DNA Way, South San Francisco, CA 94080, USA.
  • Spahn J; Genentech, Inc, 1 DNA Way, South San Francisco, CA 94080, USA.
  • Chen M; Department of Hepatobiliary Surgery, Cancer Centre of Sun Yat-sen University, Guangzhou, PR China.
  • Cheng AL; National Taiwan University Cancer Center & National Taiwan University Hospital, Taipei, Taiwan.
  • Kaseb A; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Kudo M; Department of Gastroenterology & Hepatology, Kindai University School of Medicine, Osaka, Japan.
  • Lee HC; Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Yopp A; Department of Surgery, Division of Surgical Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Chow P; Division of Surgical Oncology, National Cancer Centre, Singapore.
  • Qin S; PLA Cancer Center, People's Liberation Army (PLA) 81 Hospital, Nanjing 210016, PR China.
Future Oncol ; 16(15): 975-989, 2020 May.
Article em En | MEDLINE | ID: mdl-32352320
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Future Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Future Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos